Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Novadoc AB
AB
Active
Org 5590754031
Toftavägen 25, 233 35
Svedala
General medical practice activities
·
NACE 8621
Est. 2016 · 9 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
General medical practice activities
/
Novadoc AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 1M
1M
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 896
2 202
1 923
1 886
2 004
Staff expenses
−348
−1 164
−1 248
−1 468
—
EBITDA
1 492
884
582
338
348
Depreciation & amort.
−9
—
6
—
−0
EBIT
1 483
884
588
338
348
Net financials
−27
331
55
19
195
Profit before tax
1 752
1 537
479
647
684
Tax
−369
−326
−102
−142
−144
Net profit
1 383
1 211
376
505
540
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
5 256
4 631
4 177
4 259
4 527
Equity
4 266
3 327
2 681
2 864
2 923
Long-term debt
—
—
—
—
0
Short-term debt
400
418
289
352
271
Total debt
400
418
289
352
271
Financial ratios
5-year trend
EBITDA margin
78,7 %
This company
15,8 %
Market median
This company
Market median
398% above market
2021
2025
Equity ratio
81,2 %
This company
38,2 %
Market median
This company
Market median
113% above market
2021
2025
Return on equity
32,4 %
This company
18,4 %
Market median
This company
Market median
76% above market
2021
2025
Net profit margin
72,9 %
This company
8,1 %
Market median
This company
Market median
800% above market
2021
2025
Asset turnover
0,36×
This company
1,12×
Market median
This company
Market median
68% below market
2021
2025
Debt / equity
0,23×
This company
0,62×
Market median
This company
Market median
63% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Novadoc AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
